Ocuphire Pharma to Present at ESCRS 2023 and MODLive! Conferences in September

ESCRS presentations will feature clinical data on APX3330 in diabetic retinopathy; Nyxol data in presbyopia, dim light vision disturbance and reversal of pharmacologically induced mydriasis

FARMINGTON HILLS, Mich., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders, today announced that it will present clinical data on APX3330 and Nyxol at the 41st Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) to take place September 8th - 11th, in Vienna, Austria. In addition, Bindu Manne, Head of Market Development and Commercialization at Ocuphire, will deliver a corporate presentation at the MODLive! Conference to take place September 8th - 10th, in Nashville, TN.

ESCRS Presentations
Title:	Oral APX3330 Reduces the DRSS Worsening After 24-Weeks of Daily Treatment: Efficacy And Safety Results Of the Zeta-1 Phase 2 Trial in Diabetic Retinopathy
Author:	James Katz, MD
Abstract ID	PO106
Format	E-poster
Title:	Vega-1: A Phase 3, Double-Masked, Randomized, Placebo-Controlled Study of POS And LDP in Presbyopic Patients
Author:	Cathleen McCabe, MD
Abstract ID	PO0888
Format	E-poster
Title:	Lynx-1: Phentolamine Ophthalmic Solution for Dim Light Vision Disturbance
Presenter:	Sheraz Daya, MD
Date:	Monday, September 11, 2023
Time	5:00 - 5:06pm CEST
Room:	Lehar 1-2-3 Free paper podium 3
Abstract ID	FP23.05
Format	Paper (oral)
Title:	Treatment With 0.75% Phentolamine Ophthalmic Solution Reverses Mydriasis in Healthy Subjects: Results From Mira-2 And Mira-3, Pivotal Phase 3 Clinical Trials
Presenter:	Cathleen McCabe, MD
Date:	Monday, September 11, 2023
Time:	5:06 - 5:12pm CEST
Room:	Lehar 1-2-3 Free paper podium 3
Abstract ID	FP23.06
Format	Paper (oral)
MODLive! Presentation
Session:	Emerging Technology
Presenter:	Bindu Manne, Head of Market Development and Commercialization, Ocuphire
Date:	Friday, September 8, 2023
Time:	5:15pm CDT
Location:	Grand Hall DE, Grand Hyatt Nashville